France Blood-based Biomaker For Sports Medicine Market Size & Outlook
France blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
France blood-based biomaker for sports medicine market highlights
- The France blood-based biomaker for sports medicine market generated a revenue of USD 26.5 million in 2023 and is expected to reach USD 47.3 million by 2030.
- The France market is expected to grow at a CAGR of 8.6% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
Blood-based biomaker for sports medicine market data book summary
| Market revenue in 2023 | USD 26.5 million |
| Market revenue in 2030 | USD 47.3 million |
| Growth rate | 8.6% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, France accounted for 4.0% of the global blood-based biomaker for sports medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 86.6 million by 2030.
Ck was the largest segment with a revenue share of 18.11% in 2023. Horizon Databook has segmented the France blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
The blood-based biomarkers market for sports medicine in France is anticipated to witness significant growth, driven by advancements in clinical research and innovation from key industry players. Companies like bioMérieux are at the forefront of this development, contributing to market expansion through cutting-edge diagnostic solutions.
For instance, bioMérieux’s work on blood-based tests, such as the VIDAS TBI (GFAP, UCH-L1) test for traumatic brain injury, exemplifies the innovation propelling the field forward. In addition to corporate efforts, France’s robust clinical research environment supports developing and validating new biomarkers, enhancing their application in sports medicine.
This research focus, combined with technological advancements and strategic investments, is expected to facilitate market growth in France, offering promising tools for injury diagnosis, monitoring, and recovery in athletes.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)
France Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
